Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Scientific Reports|January 10, 2024
Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancerTara A Seibert, Lei Shi, Sandra Althouse, et al.
Breast Cancer Research : BCR|May 4, 2018
Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasisMaria B Padua, Poornima Bhat-Nakshatri, Manjushree Anjanappa, et al.
Journal for Immunotherapy of Cancer|July 15, 2025
Randomized phase II study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small-cell lung cancer (NSCLC): Big Ten Cancer Research Consortium LUN16-081Greg Durm, Hirva Mamdani, Sandra Althouse, et al.
JAMA Oncology|June 6, 2024
Comprehensive Audiologic Analyses After Cisplatin-Based ChemotherapyVictoria A Sanchez, Paul C Dinh, Patrick O Monahan, et al.
Clinical Epigenetics|February 10, 2022
Aberrant epigenetic and transcriptional events associated with breast cancer riskNatascia Marino, Rana German, Ram Podicheti, et al.
Cancer|April 14, 2026
A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancerKathy D Miller, Alexandra Thomas, Sandra Althouse, et al.
JNCI Cancer Spectrum|August 14, 2024
Cognitive function in long-term testicular cancer survivors: impact of modifiable factorsPaul C Dinh, Patrick O Monahan, Chunkit Fung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2018
Histology, Tumor Volume, and Radiation Dose Predict Outcomes in NSCLC Patients After Stereotactic Ablative RadiotherapyKevin Shiue, Alberto Cerra-Franco, Ronald Shapiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based ChemotherapyChunkit Fung, Howard D Sesso, Annalynn M Williams, et al.
Eclinicalmedicine|April 13, 2026
Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort studyVictoria A Sanchez, Paul C Dinh, Patrick O Monahan, et al.
Pageof 4